Raspa Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.68 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 87.59%
- Ebitda 83.87%
- Net Worth 1236.92%
- Total Assets 344.42%
About Raspa Pharma
Raspa Pharma Private Limited (RPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 August 2020 (Four years and six months 21 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sapna Agarwal, Ram Agarwal, and Padmakshi Agarwal serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24297UP2020PTC132251
- Company No.
132251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Raspa Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Agarwal  | Director | 05-Aug-2020 | Current |
| Sapna Agarwal | Director | 05-Aug-2020 | Current |
| Padmakshi Agarwal | Director | 05-Aug-2020 | Current |
Financial Performance of Raspa Pharma.
Raspa Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 87.59% increase in profit. The company's net worth Soared by an impressive increase of 1236.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raspa Pharma?
In 2023, Raspa Pharma had a public holding of 1.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raspa Innovation Lab Private LimitedRam Agarwal and Padmakshi Agarwal are mutual person
Barbarik Enterprises LlpSapna Agarwal is a mutual person
- Manomay Enterprises Llp
Sapna Agarwal is a mutual person
- Vishwamurti Infracon Llp
Sapna Agarwal is a mutual person
- Brijwasi Stock Brokers Private Limited
Sapna Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Raspa Pharma?
Raspa Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raspa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raspa Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.